Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease

被引:101
作者
Brück, A [1 ]
Aalto, S [1 ]
Nurmi, E [1 ]
Bergman, J [1 ]
Rinne, JO [1 ]
机构
[1] Univ Turku, Turku PET Ctr, FIN-20521 Turku, Finland
关键词
Parkinson's disease; PET; 6-[F-18]fluoro-L-dopa; frontal lobe functions; cognition; attention;
D O I
10.1016/j.neurobiolaging.2004.07.014
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
yPatients with Parkinson's disease (PD) have already at the early stages of the disease impaired performance especially in tests measuring frontal lobe functions such as attention. The pathophysiological basis of these deficits is unclear. In the present study, 21 non-demented, non-medicated patients at the early stage of PD and 24 healthy controls underwent a positron emission tomography (PET) scan with 6[F-18]fluoro-L-dopa (Fdopa) as the tracer. In addition, the PD patients performed a neuropsychological test battery, including a test measuring sustained attention (VIG) and a test requiring suppressed attention (Stroop). Both voxel-based Statistical Parametric Mapping (SPM) and automated region of interest (ROI) analysis were employed. Compared to controls, the PD patients had decreased Fdopa uptake in the striatum and a large cortical area of increased Fdopa uptake. The reaction time in the VIG test correlated positively with the Fdopa uptake of the dorsolateral prefrontal cortex and the performance in the Stroop test correlated negatively with the Fdopa uptake in an area including the medial frontal cortex and the anterior cingulate. The results show that cortical Fdopa uptake is increased in early non-medicated PD and suggest that the changes in frontal Fdopa uptake are related to cognitive impairments found in early PD. (c) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:891 / 898
页数:8
相关论文
共 53 条
  • [1] Agid Y., 1987, MOVEMENT DISORD, V2, P166
  • [2] Noise stress impairs prefrontal cortical cognitive function in monkeys - Evidence for a hyperdopaminergic mechanism
    Arnsten, AFT
    Goldman-Rakic, PS
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (04) : 362 - 368
  • [3] Bergman J., 1994, Journal of Labelled Compounds and Radiopharmaceuticals, V35, P476
  • [4] Bowen F P, 1976, Res Publ Assoc Res Nerv Ment Dis, V55, P169
  • [5] THE RELATIONSHIP BETWEEN LOCOMOTOR DISABILITY, AUTONOMIC DYSFUNCTION, AND THE INTEGRITY OF THE STRIATAL DOPAMINERGIC SYSTEM IN PATIENTS WITH MULTIPLE SYSTEM ATROPHY, PURE AUTONOMIC FAILURE, AND PARKINSONS-DISEASE, STUDIED WITH PET
    BROOKS, DJ
    SALMON, EP
    MATHIAS, CJ
    QUINN, N
    LEENDERS, KL
    BANNISTER, R
    MARSDEN, CD
    FRACKOWIAK, RSJ
    [J]. BRAIN, 1990, 113 : 1539 - 1552
  • [6] The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease
    Broussolle, E
    Dentresangle, C
    Landais, P
    Garcia-Larrea, L
    Pollak, P
    Croisile, B
    Hibert, O
    Bonnefoi, F
    Galy, G
    Froment, JC
    Comar, D
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 166 (02) : 141 - 151
  • [7] Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus
    Brück, A
    Portin, R
    Lindell, A
    Laihinen, A
    Bergman, J
    Haaparanta, M
    Solin, O
    Rinne, JO
    [J]. NEUROSCIENCE LETTERS, 2001, 311 (02) : 81 - 84
  • [8] Imaging cognition II: An empirical review of 275 PET and fMRI studies
    Cabeza, R
    Nyberg, L
    [J]. JOURNAL OF COGNITIVE NEUROSCIENCE, 2000, 12 (01) : 1 - 47
  • [9] L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease
    Cools, R
    Barker, RA
    Sahakian, BJ
    Robbins, TW
    [J]. NEUROPSYCHOLOGIA, 2003, 41 (11) : 1431 - 1441
  • [10] COOLS R, 1999, MENTAL DYSFUNCTION P, P142